InCephalo
Biologics & Biosimilars · Health Care
Overview
InCephalo engineers compartment-locked biologics to treat glioblastoma. Our C-Lock™ technology delivers potent immune activation to brain tumors without the risks of systemic exposure.
Funding and backers
Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Alentis Therapeutics
Similar startupsby what they do, their industry and backers
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Leading the advancement of biologics for targeted immune regulation & restoration.
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
Find out more about Biodextris, your premier biologics development and manufacturing partner. Check out our cutting-edge solutions.
Biologics Beyond Boundaries. Developing first-in-class therapeutics to treat brain cancers and CNS diseases.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
High-Tech GründerfondsVia a fund
516 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Basel
Switzerland
HQ